J.'.~"";i'

References
• Walker J.J. and Gant N.F. (1997): Hypertension in pregnancy. 5th
ed by champan and Hall London. vol I, P : 39-65 .
• Walker S.W. (1990) : Apolipoproteins and hyperlipidemia. Clin
chemi; 36 (2) : 192-197 .
• Walsh S.W. (1988) : Progesteron and estradiol production by normal
and preeclamptic placenta .AmJ. Obstet & Gynecol ; 71 : 222-6 .
• Walsh. S.w. (1989) : Low dose aspirin, treatment for imbalance of
increased thromboxane and decreased prostacyclin in preeclampsia .
AmJ. Perinatology; 27: 120-7.
• Walsh S.W. (1990) : Physiology of low dose aspirin Therapy for
prevention ofpreeclampsia. Semin perinato. 14 : 152-70 .
• Walsh SW. (1994): Lipid peroxidation in pregnancy. Hypertension
pregn. 13 : 1-31.
• Wang X.L.; Tam c., Me Gedie R.M. and Wilken D.E.L. (1994) :
Determinats of Severity ofCoronary artery disease in Australian men
and women. Circulation; 89: 1974-1978.
• Wang J; Mimuro,S.; Lahoud R.; TrudingerB. and Wang,
x.l.(1998) : Elevated levels of lipoprotein (a) in women with
preeclampsia .AmJ. Obstet & Gynecol; 178 : 146-9.
• Wein. R.J. (1979) : Hypertension and Eclampsia in pregnancy.
Practical obstetric problems, 5th. Ed.
• Weiner .c.p; Brandt, and J. (1982): A modified activated partial
thromboplastin time with the use ofaminotic fluid. A.1nJ. Obstet &
Gynecol144 : 234.
• Weiner c.P.; Martinez E, Zhulkchoasdi A. and Chestrut D.
(1989) : In vitro Release of Endothelium derived relasing factor by
acetylation is increased during the guinea pig pregnancy .AmJ. Obstet
gynecol, 161 : 1599.
127